Alzheimer’s Research Papers ~ April 2002 ~ Beta Amyloid Blog
Thompson VF, Saldaña S, Cong J, Luedke DM, Goll DE. The calpain system in human placenta. Life Sci. 2002 Apr 21;70(21):2493-508.
Mori M, Nakagami H, Morishita R, Mitsuda N, Yamamoto K, Yoshimura S, Ohkubo N, Sato N, Ogihara T, Kaneda Y. N141I mutant presenilin-2 gene enhances neuronal cell death and decreases bcl-2 expression. Life Sci. 2002 Apr 21;70(21):2567-80.
Yip CM, Darabie AA, McLaurin J. Abeta42-Peptide assembly on lipid bilayers. J Mol Biol. 2002 Apr 19;318(1):97-107.
Fidani L, Goulas A, Mirtsou V, Petersen RC, Tangalos E, Crook R, Hardy J. Interleukin-1A polymorphism is not associated with late onset Alzheimer's disease. Neurosci Lett. 2002 Apr 19;323(1):81-3. ,
D'Andrea MR, Nagele RG, Gumula NA, Reiser PA, Polkovitch DA, Hertzog BM, Andrade-Gordon P. Lipofuscin and Abeta42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains. Neurosci Lett. 2002 Apr 19;323(1):45-9.
Bishop GM, Robinson SR, Smith MA, Perry G, Atwood CS. Call for Elan to publish Alzheimer's trial details. Nature. 2002 Apr 18;416(6882):677.
Münch G, Shepherd CE, McCann H, Brooks WS, Kwok JB, Arendt T, Hallupp M, Schofield PR, Martins RN, Halliday GM. Intraneuronal advanced glycation endproducts in presenilin-1 Alzheimer's disease. Neuroreport. 2002 Apr 16;13(5):601-4. ,
Evin G, Smith MJ, Tziotis A, McLean C, Canterford L, Sharples RA, Cappai R, Weidemann A, Beyreuther K, Cotton RG, Masters CL, Culvenor JG. Alternative transcripts of presenilin-1 associated with frontotemporal dementia. Neuroreport. 2002 Apr 16;13(5):719-23.
Davidsson P, Westman-Brinkmalm A, Nilsson CL, Lindbjer M, Paulson L, Andreasen N, Sjögren M, Blennow K. Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. Neuroreport. 2002 Apr 16;13(5):611-5.
Parkin ET, Trew A, Christie G, Faller A, Mayer R, Turner AJ, Hooper NM. Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-alpha. Biochemistry. 2002 Apr 16;41(15):4972-81.
Frenkel D, Solomon B. Filamentous phage as vector-mediated antibody delivery to the brain. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5675-9.
Perutz MF, Pope BJ, Owen D, Wanker EE, Scherzinger E. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid beta-peptide of amyloid plaques. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5596-600.
Perutz MF, Finch JT, Berriman J, Lesk A. Amyloid fibers are water-filled nanotubes. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5591-5.
Uterga Valiente JM, Rodr guez Iriarte ML, Gonz lez Garc a AI, Taramundi Arg eso S, Lvaro Gonz lez LC, Cortina Garaicorta C. [Dementia with frontal lobe atrophy: clinical study from 18 patients with cognitive impairment and frontal lobe involvement detected by structural and functional neuroimaging] Rev Neurol. 2002 Apr 16;34(8):709-14.
Akatsu H, Takahashi M, Matsukawa N, Ishikawa Y, Kondo N, Sato T, Nakazawa H, Yamada T, Okada H, Yamamoto T, Kosaka K. Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci. 2002 Apr 15;196(1-2):63-9.
Boncristiano S, Calhoun ME, Kelly PH, Pfeifer M, Bondolfi L, Stalder M, Phinney AL, Abramowski D, Sturchler-Pierrat C, Enz A, Sommer B, Staufenbiel M, Jucker M. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci. 2002 Apr 15;22(8):3234-43.
Yaffe K, Lui LY, Grady D, Stone K, Morin P. Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol Psychiatry. 2002 Apr 15;51(8):677-82.
Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, Wisniewski T, Robakis NK. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 2002 Apr 15;21(8):1948-56.
Srivastava RA, Jain JC. Scavenger receptor class B type I expression and elemental analysis in cerebellum and parietal cortex regions of the Alzheimer's disease brain. J Neurol Sci. 2002 Apr 15;196(1-2):45-52.
Muñoz FJ, Opazo C, Gil-Gómez G, Tapia G, Fernández V, Valverde MA, Inestrosa NC. Vitamin E but not 17beta-estradiol protects against vascular toxicity induced by beta-amyloid wild type and the Dutch amyloid variant. J Neurosci. 2002 Apr 15;22(8):3081-9.
Habeck M. New insights into Alzheimer's disease. Drug Discov Today. 2002 Apr 15;7(8):441-442.
Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet. 2002 Apr 13;359(9314):1283-90.
Charatan F. Medicare will now cover some treatments for Alzheimer's disease. BMJ. 2002 Apr 13;324(7342):872.
Hetényi C, Szabó Z, Klement E, Datki Z, Körtvélyesi T, Zarándi M, Penke B. Pentapeptide amides interfere with the aggregation of beta-amyloid peptide of Alzheimer's disease. Biochem Biophys Res Commun. 2002 Apr 12;292(4):931-6.
Sai X, Kawamura Y, Kokame K, Yamaguchi H, Shiraishi H, Suzuki R, Suzuki T, Kawaichi M, Miyata T, Kitamura T, De Strooper B, Yanagisawa K, Komano H. Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein. J Biol Chem. 2002 Apr 12;277(15):12915-20.
Fidani L, Compton D, Hardy J, Petersen RC, Tangalos E, Mirtsou V, Goulas A, De Vrieze FW. No association between the lipoprotein lipase S447X polymorphism and Alzheimer's disease. Neurosci Lett. 2002 Apr 12;322(3):192-4. ,
Mounier N, André M, Lepage E. Nonsteroidal drugs and Alzheimer's disease. N Engl J Med. 2002 Apr 11;346(15):1171-3.
Press D. Nonsteroidal drugs and Alzheimer's disease. N Engl J Med. 2002 Apr 11;346(15):1171-3.
Hüll M, Lieb K, Fiebich BL. Nonsteroidal drugs and Alzheimer's disease. N Engl J Med. 2002 Apr 11;346(15):1171-3.
Sood A. Nonsteroidal drugs and Alzheimer's disease. N Engl J Med. 2002 Apr 11;346(15):1171-3.
Delobel P, Flament S, Hamdane M, Delacourte A, Vilain JP, Buée L. Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities. FEBS Lett. 2002 Apr 10;516(1-3):151-5.
Koudinov AR, Berezov TT, Koudinova NV. Cholesterol and Alzheimer's disease: is there a link? Neurology. 2002 Apr 9;58(7):1135.
Aisen PS, Schmeidler J, Pasinetti GM. Randomized pilot study of nimesulide treatment in Alzheimer's disease. Neurology. 2002 Apr 9;58(7):1050-4.
Dal Forno G, Carson KA, Brookmeyer R, Troncoso J, Kawas CH, Brandt J. APOE genotype and survival in men and women with Alzheimer's disease. Neurology. 2002 Apr 9;58(7):1045-50. ,
Matsubara-Tsutsui M, Yasuda M, Yamagata H, Nomura T, Taguchi K, Kohara K, Miyoshi K, Miki T. Molecular evidence of presenilin 1 mutation in familial early onset dementia. Am J Med Genet. 2002 Apr 8;114(3):292-8.
Myllykangas L, Polvikoski T, Reunanen K, Wavrant-De Vrieze F, Ellis C, Hernandez D, Sulkava R, Kontula K, Verkkoniemi A, Notkola IL, Hardy J, Perez-Tur J, Haltia MJ, Tienari PJ. ApoE epsilon3-haplotype modulates Alzheimer beta-amyloid deposition in the brain. Am J Med Genet. 2002 Apr 8;114(3):288-91. ,
Greenfield JP, Leung LW, Cai D, Kaasik K, Gross RS, Rodriguez-Boulan E, Greengard P, Xu H. Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J Biol Chem. 2002 Apr 5;277(14):12128-36.
Sun W, Qureshi HY, Cafferty PW, Sobue K, Agarwal-Mawal A, Neufield KD, Paudel HK. Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules. J Biol Chem. 2002 Apr 5;277(14):11933-40.
Haas J, Storch-Hagenlocher B, Biessmann A, Wildemann B. Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro. Neurosci Lett. 2002 Apr 5;322(2):121-5.
Hauss-Wegrzyniak B, Wenk GL. Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle. Neurosci Lett. 2002 Apr 5;322(2):75-8.
Ahn BH, Rhim H, Kim SY, Sung YM, Lee MY, Choi JY, Wolozin B, Chang JS, Lee YH, Kwon TK, Chung KC, Yoon SH, Hahn SJ, Kim MS, Jo YH, Min do S. alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells. J Biol Chem. 2002 Apr 5;277(14):12334-42.
Chou KC, Howe WJ. Prediction of the tertiary structure of the beta-secretase zymogen. Biochem Biophys Res Commun. 2002 Apr 5;292(3):702-8.
Kaplan B, Pras M. Combined use of micro-preparative gel electrophoresis and reversed-phase high-performance liquid chromatography for purification of amyloid beta peptides deposited in brains of Alzheimer's disease patients. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Apr 5;769(2):363-70.
Kiuchi Y, Isobe Y, Fukushima K, Kimura M. Disassembly of amyloid beta-protein fibril by basement membrane components. Life Sci. 2002 Apr 5;70(20):2421-31.
Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002 Apr 4;416(6880):535-9.
Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 2002 Apr 4;416(6880):507-11.
Smith AD. Imaging the progression of Alzheimer pathology through the brain. Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4135-7.
Hashimoto T, Wakabayashi T, Watanabe A, Kowa H, Hosoda R, Nakamura A, Kanazawa
Short RA, Graff-Radford NR, Adamson J, Baker M, Hutton M. Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch Neurol. 2002 Apr;59(4):611-5.
Graff-Radford NR, Green RC, Go RC, Hutton ML, Edeki T, Bachman D, Adamson JL, Griffith P, Willis FB, Williams M, Hipps Y, Haines JL, Cupples LA, Farrer LA. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects. Arch Neurol. 2002 Apr;59(4):594-600.
Wang X, DeKosky ST, Luedecking-Zimmer E, Ganguli M, Kamboh I. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease. Hum Genet. 2002 Apr;110(4):356-65. ,
Riviere GR, Riviere KH, Smith KS
Royall DR, Palmer R, Mulroy AR, Polk MJ, Román GC, David JP, Delacourte A. Pathological determinants of the transition to clinical dementia in Alzheimer's disease. Exp Aging Res. 2002 Apr-Jun;28(2):143-62.
Casolini P, Catalani A, Zuena AR
Zandi PP, Breitner JC, Anthony JC. Is pharmacological prevention of Alzheimer's a realistic goal? Expert Opin Pharmacother. 2002 Apr;3(4):365-380.
Müller U, Kins S. APP on the move. Trends Mol Med. 2002 Apr 1;8(4):152-5.
Lleó A, Rey M, Castellví M, Ferrer I, Blesa R. [Asymmetric myoclonic parietal syndrome in a patient with Alzheimer's disease mimicking corticobasal degeneration] Neurologia. 2002 Apr;17(4):223-226.
Soler T, Pujol M, Peña-Casanova J, Hernández G, Sol J, Aguilar M, Blesa R. [Adaptation and standardization of the Geriatric Evaluation of Relative's Rating Instrument (GERRI) for Spain] Neurologia. 2002 Apr;17(4):193-199.
Haan MN, Jagust WJ, Galasko D, Kaye J. Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease. Arch Neurol. 2002 Apr;59(4):588-93.
Perini G, Della-Bianca V, Politi V, Della Valle G, Dal-Pra I, Rossi F, Armato U. Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med. 2002 Apr 1;195(7):907-18.
Grön G, Bittner D, Schmitz B, Wunderlich AP, Riepe MW. Subjective memory complaints: objective neural markers in patients with Alzheimer's disease and major depressive disorder. Ann Neurol. 2002 Apr;51(4):491-8.
Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen FA, Goetz CG, Mastaglia F, Stajich JM, Gibson RA, Middleton LT, Saunders AM, Scott BL, Small GW, Nicodemus KK, Reed AD, Schmechel DE, Welsh-Bohmer KA, Conneally PM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet. 2002 Apr 1;70(4):985-93.
Chopin P, Colpaert FC, Marien M. Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents. J Pharmacol Exp Ther. 2002 Apr;301(1):187-96.
Gander R, Eller P, Kaser S, Theurl I, Walter D, Sauper T, Ritsch A, Patsch JR, Föger B. Molecular characterization of rabbit phospholipid transfer protein. Choroid plexus and ependyma synthesize high levels of phospholipid transfer protein. J Lipid Res. 2002 Apr;43(4):636-45.
Gregory C, Lough S, Stone V, Erzinclioglu S, Martin L, Baron-Cohen S, Hodges JR. Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer's disease: theoretical and practical implications. Brain. 2002 Apr;125(Pt 4):752-64.
Pickering-Brown SM, Richardson AM, Snowden JS, McDonagh AM, Burns A, Braude W, Baker M, Liu WK, Yen SH, Hardy J, Hutton M, Davies Y, Allsop D, Craufurd D, Neary D, Mann DM. Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain. 2002 Apr 1;125(Pt 4):732-51.
Gnjec A, Fonte JA, Atwood C, Martins RN. Transition metal chelator therapy--a potential treatment for Alzheimer's disease? Front Biosci. 2002 Apr 1;7:d1016-23.
Kril JJ, Patel S, Harding AJ, Halliday GM. Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation. Acta Neuropathol (Berl). 2002 Apr;103(4):370-6.
Peila R, Rodriguez BL, Launer LJ, . Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes. 2002 Apr 1;51(4):1256-62.
Heneka MT, Galea E, Gavriluyk V, Dumitrescu-Ozimek L, Daeschner J, O'Banion MK, Weinberg G, Klockgether T, Feinstein DL. Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease. J Neurosci. 2002 Apr 1;22(7):2434-42.
Naumann T, Casademunt E, Hollerbach E, Hofmann J, Dechant G, Frotscher M, Barde YA. Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons. J Neurosci. 2002 Apr 1;22(7):2409-18.
Kakimura J, Kitamura Y, Takata K, Umeki M, Suzuki S, Shibagaki K, Taniguchi T, Nomura Y, Gebicke-Haerter PJ, Smith MA, Perry G, Shimohama S. Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J. 2002 Apr;16(6):601-3.
Anderton BH. Ageing of the brain. Mech Ageing Dev. 2002 Apr;123(7):811-7.
Kovács GG, Budka H. Aging, the brain and human prion disease. Exp Gerontol. 2002 Apr;37(4):603-5.
Buxbaum JD, Cullen EI, Friedhoff LT. Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients. Front Biosci. 2002 Apr 1;7:a50-9.
Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):491-7.
Yamada M, Sodeyama N, Itoh Y, Otomo E, Matsushita M, Mizusawa H. No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy. Stroke. 2002 Apr;33(4):896-900. ,
Hu YY, He SS, Wang X, Duan QH, Grundke-Iqbal I, Iqbal K, Wang J. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am J Pathol. 2002 Apr;160(4):1269-78. ,
Münch G, Robinson SR. Alzheimer's vaccine: a cure as dangerous as the disease? J Neural Transm. 2002 Apr;109(4):537-9.
Caterini F, Della SS, Spinnler H, Stangalino C, Tumbull OH. Object recognition and object orientation in Alzheimer's disease. Neuropsychology. 2002 Apr;16(2):146-55.
Jacobson MW, Delis DC, Bondi MW, Salmon DP. Do neuropsychological tests detect preclinical Alzheimer's disease: individual-test versus cognitive-discrepancy score analyses. Neuropsychology. 2002 Apr;16(2):132-9.
Woodruff-Pak DS, Green JT, Pak JT, Heifets B, Pak MH. The effect of scopolamine in older rabbits tested in the 750 ms delay eyeblink classical conditioning procedure. Integr Physiol Behav Sci. 2002 Apr-Jun;37(2):103-13.
Nguyen KC, Rosales JL, Barboza M, Lee KY. Controversies over p25 in Alzheimer's disease. J Alzheimers Dis. 2002 Apr;4(2):123-6.
Zhang S, Janciauskiene S. Multi-functional capability of proteins: alpha1-antichymotrypsin and the correlation with Alzheimer's disease. J Alzheimers Dis. 2002 Apr;4(2):115-22.
Meli M, Perier C, Ferron C, Parssegny F, Denis C, Gonthier R, Laurent B, Reynaud E, Frey J, Chamson A. Serum pentosidine as an indicator of Alzheimer's disease. J Alzheimers Dis. 2002 Apr;4(2):93-6.
Lange R, Donathan CL, Hughes LF. Assessing olfactory abilities with the University of Pennsylvania smell identification test: a Rasch scaling approach. J Alzheimers Dis. 2002 Apr;4(2):77-91.
Ruof J, Mittendorf T, Pirk O, von der Schulenburg JM. Diffusion of innovations: treatment of Alzheimer's disease in Germany. Health Policy. 2002 Apr;60(1):59-66.
Casolini P, Catalani A, Zuena AR, Angelucci L. Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat. J Neurosci Res. 2002 Apr 1;68(1):89-96.
Souder E, Chastain JR, Williams RD. Dementia in the new millennium. Medsurg Nurs. 2002 Apr;11(2):61-9; quiz 70.
Parasuraman R, Greenwood PM, Sunderland T. The apolipoprotein E gene, attention, and brain function. Neuropsychology. 2002 Apr;16(2):254-74.
Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li ST, Takei K, Matsui H. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci. 2002 Apr 1;22(7):2590-7.
Meehan KM, Wang H, David SR, Nisivoccia JR, Jones B, Beasley CM, Feldman PD, Mintzer JE, Beckett LM, Breier A. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology. 2002 Apr;26(4):494-504.
Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms. Am J Clin Nutr. 2002 Apr;75(4):616-58.
McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, Kerrigan DF, Ransom NL, Tahzib NG, Reitsamer HA, Levkovitch-Verbin H, Quigley HA, Zack DJ. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1077-87.
Glosser G, Gallo JL, Clark CM, Grossman M. Memory encoding and retrieval in frontotemporal dementia and Alzheimer's disease. Neuropsychology. 2002 Apr;16(2):190-6.
Chen Z, Xu AJ, Li R, Wei EQ. Reversal of scopolamine-induced spatial memory deficits in rats by TAK-1471. Acta Pharmacol Sin. 2002 Apr;23(4):355-60.
de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 2002 Apr 1;33(4):1152-62.
Cibula JE, Eisenschenk S, Gold M, Eskin TA, Gilmore RL, Heilman KM. Progressive dementia and hypersomnolence with dream-enacting behavior: oneiric dementia. Arch Neurol. 2002 Apr;59(4):630-4.
Fagan AM, Watson M, Parsadanian M, Bales KR, Paul SM, Holtzman DM. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease. Neurobiol Dis. 2002 Apr;9(3):305-18. ,
Budson AE, Sitarski J, Daffner KR, Schacter DL. False recognition of pictures versus words in Alzheimer's disease: the distinctiveness heuristic. Neuropsychology. 2002 Apr;16(2):163-73.
Sisodia SS, St George-Hyslop PH. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat Rev Neurosci. 2002 Apr;3(4):281-90.
Findeis MA. Peptide inhibitors of Beta amyloid aggregation. Curr Top Med Chem. 2002 Apr;2(4):417-23.
Lau LF, Schachter JB, Seymour PA, Sanner MA. Tau protein phosphorylation as a therapeutic target in Alzheimer's disease. Curr Top Med Chem. 2002 Apr;2(4):395-415.
Wolfe MS. Secretase as a target for Alzheimer's disease. Curr Top Med Chem. 2002 Apr;2(4):371-83.
Roggo S. Inhibition of BACE, a Promising Approach to Alzheimer's Disease Therapy. Curr Top Med Chem. 2002 Apr;2(4):359-70.
Messer Jr WS. Cholinergic agonists and the treatment of Alzheimer s disease. Curr Top Med Chem. 2002 Apr;2(4):353-8.
Jordan-Sciutto KL, Malaiyandi LM, Bowser R. Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. J Neuropathol Exp Neurol. 2002 Apr;61(4):358-67.
Zhu Y, Lin L, Kim S, Quaglino D, Lockshin RA, Zakeri Z. Cyclin dependent kinase 5 and its interacting proteins in cell death induced in vivo by cyclophosphamide in developing mouse embryos. Cell Death Differ. 2002 Apr;9(4):421-30.
Dib M, Garrel C, Favier A, Robin V, Desnuelle C. Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease? J Neurol. 2002 Apr;249(4):367-74.
Bodi I, Achawal SV, Sharr MM, Lantos PL. Amyloid angiopathy in a brain biopsy of a suspected haemorrhagic tumour: case report. Neuropathol Appl Neurobiol. 2002 Apr;28(2):165.
Mann DM, Thaker U, McDonagh AM, Lendon CL. Deposition of tau in the brain in Alzheimer's disease is related to the amount of Abeta40 but not Abeta42(43) deposits and the presence of apolipoprotein E epsilon4 allele. Neuropathol Appl Neurobiol. 2002 Apr;28(2):148-9.
Floyd RA, Hensley K, Forster MJ, Kelleher-Anderson JA, Wood PL. Nitrones as neuroprotectants and antiaging drugs. Ann N Y Acad Sci. 2002 Apr;959:321-9.
Teahan O, Slade JY, Perry RH, Ballard CG, Kalaria RN. White matter pathology in Alzheimer's disease and vascular dementia: quantification by amyloid-beta precursor protein immunocytochemistry. Neuropathol Appl Neurobiol. 2002 Apr;28(2):168.
Burggren AC, Bookheimer SY. Structural and functional neuroimaging in Alzheimer's disease: an update. Curr Top Med Chem. 2002 Apr;2(4):385-93.
Jacobsen JS. Alzheimer s disease: an overview of current and emerging therapeutic strategies. Curr Top Med Chem. 2002 Apr;2(4):343-52.
Tanaka M, Fukuyama H, Yamauchi H, Narita M, Nabatame H, Yokode M, Fujimoto N, Kita T, Murakami M. Regional cerebral blood flow abnormalities in nondemented patients with memory impairment. J Neuroimaging. 2002 Apr;12(2):112-8.
Pansari K, Gupta A, Thomas P. Alzheimer's disease and vascular factors: facts and theories. Int J Clin Pract. 2002 Apr;56(3):197-203.
Helmes E, Merskey H, Fox H, Bowler JV, Hachinski VC. Profiles of cognitive decline in Alzheimer disease. Alzheimer Dis Assoc Disord. 2002 Apr-Jun;16(2):123-7.
Hashimoto K, Iyo M. [Amyloid cascade hypothesis of Alzheimer's disease and alpha 7 nicotinic receptor] Nihon Shinkei Seishin Yakurigaku Zasshi. 2002 Apr;22(2):49-53.
Bullock R. The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis. Int J Clin Pract. 2002 Apr;56(3):206-14.
Scharre DW, Chang SI. Cognitive and behavioral effects of quetiapine in Alzheimer disease patients. Alzheimer Dis Assoc Disord. 2002 Apr-Jun;16(2):128-30.
Cott CA, Dawson P, Sidani S, Wells D. The effects of a walking/talking program on communication, ambulation, and functional status in residents with Alzheimer disease. Alzheimer Dis Assoc Disord. 2002 Apr-Jun;16(2):81-7.
Cardinali DP, Brusco LI, Liberczuk C, Furio AM. REVIEW. The use of melatonin in Alzheimer's disease. Neuroendocrinol Lett. 2002 Apr;23 Suppl 1:20-3.
Kaeberlein M, Jegalian B, McVey M. AGEID: a database of aging genes and interventions. Mech Ageing Dev. 2002 Apr;123(8):1115-9.
Youdim MB, Weinstock M. Novel neuroprotective anti-Alzheimer drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline. Mech Ageing Dev. 2002 Apr;123(8):1081-6.
Chiu E. Alzheimer disease. Current treatment options. Aust Fam Physician. 2002 Apr;31(4):323-6.
Popplewell P, Phillips P. Is it dementia? Which one? Aust Fam Physician. 2002 Apr;31(4):319-21.
Khuebachova M, Verzillo V, Skrabana R, Ovecka M, Vaccaro P, Panni S, Bradbury A, Novak M. Mapping the C terminal epitope of the Alzheimer's disease specific antibody MN423. J Immunol Methods. 2002 Apr 1;262(1-2):205-15.
Chavoix C, Blaizot X, Meguro K, Landeau B, Baron JC. Excitotoxic lesions of the rhinal cortex in the baboon differentially affect visual recognition memory, habit memory and spatial executive functions. Eur J Neurosci. 2002 Apr;15(7):1225-36.
Yang L, He HY, Zhang XJ. Increased expression of intranuclear AChE involved in apoptosis of SK-N-SH cells. Neurosci Res. 2002 Apr;42(4):261-8.
Vercelletto M, Martinez F, Lanier S, Magne C, Jaulin P, Bourin M. Negative symptoms, depression and Alzheimer's disease. Int J Geriatr Psychiatry. 2002 Apr;17(4):383-7.
Kálmán J, Szakács R, Török T, Rózsa Z, Barzó P, Rudas L, Papp JG, Janka Z. Decreased cutaneous vasodilatation to isometric handgrip exercise in Alzheimer's disease. Int J Geriatr Psychiatry. 2002 Apr;17(4):371-4.
Weiser M, Rotmensch HH, Korczyn AD, Hartman R, Cicin-Sain A, Anand R. A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances. Int J Geriatr Psychiatry. 2002 Apr;17(4):343-6.
Kockler M, Nitardy A, Papassotiropoulos A, Ptok U, Maier W, Heun R. Physical disorders and causes of death in relatives of Alzheimer's disease patients. Int J Geriatr Psychiatry. 2002 Apr;17(4):335-42.
Lu KP, Liou YC, Zhou XZ. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 2002 Apr;12(4):164-72.
Kawai H, Kawamura M, Mochizuki S, Yamanaka K, Arakaki H, Tanaka K, Kawachi J. [Longitudinal study of procedural memory in patients with Alzheimer-type dementia] No To Shinkei. 2002 Apr;54(4):307-11.
von Linstow Roloff E, Platt B, Riedel G. Long-term study of chronic oral aluminum exposure and spatial working memory in rats. Behav Neurosci. 2002 Apr;116(2):351-6.
Bartrés-Faz D, Clemente IC, Monràs M, Muñoz M, López-Alomar A, Valveny N, Moral P, Gual A, Sánchez-Turet M, Guardia J, Junqué C. Relation of Apo E and ACE genes to cognitive performance in chronic alcoholic patients. Addict Biol. 2002 Apr;7(2):227-33.
Berendse HW, Booij J, Stoffers D, Ponsen MM, Hijman R, Wolters ECh. [Presymptomatic detection of Parkinson's disease] Tijdschr Gerontol Geriatr. 2002 Apr;33(2):70-7.
de Jager CA, Milwain E, Budge M. Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests. Psychol Med. 2002 Apr;32(3):483-91.
Moretti R, Torre P, Antonello RM, Cazzato G, Bava A. Ten-point clock test: a correlation analysis with other neuropsychological tests in dementia. Int J Geriatr Psychiatry. 2002 Apr;17(4):347-53.
Hogervorst E, Smith AD. The interaction of serum folate and estradiol levels in Alzheimer's disease. Neuro Endocrinol Lett. 2002 Apr 1;23(2):155-60.
Kwak S. [Alzheimer disease] Nippon Rinsho. 2002 Apr;60 Suppl 4:412-6.
Reeves RR, Struve FA, Patrick G. The effects of donepezil on quantitative EEG in patients with Alzheimer's disease. Clin Electroencephalogr. 2002 Apr;33(2):93-6.
Kikuchi M, Wada Y, Koshino Y. Differences in EEG harmonic driving responses to photic stimulation between normal aging and Alzheimer's disease. Clin Electroencephalogr. 2002 Apr;33(2):86-92.
King DL, Arendash GW. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol Behav. 2002 Apr;75(5):627-42.
McMurray RW, Hardy KJ. Cox-2 inhibitors: today and tomorrow. Am J Med Sci. 2002 Apr;323(4):181-9.
Paragh G, Balla P, Katona E, Seres I, Egerházi A, Degrell I. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci. 2002 Apr;252(2):63-7.
Sacchettini JC, Kelly JW. Therapeutic strategies for human amyloid diseases. Nat Rev Drug Discov. 2002 Apr;1(4):267-75.
Wang Y, Wang Q, Wang J. [Detection of level and mutation of neurofilament mRNA in Alzheimer's disease] Zhonghua Yi Xue Za Zhi. 2002 Apr;82(8):519-22.
Bogdanovic N, Corder E, Lannfelt L, Winblad B. APOE polymorphism and clinical duration determine regional neuropathology in Swedish APP(670, 671) mutation carriers: implications for late-onset Alzheimer's disease. J Cell Mol Med. 2002 Apr-Jun;6(2):199-214.
Möller JC, Hamer HM, Oertel WH, Rosenow F. Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS). Seizure. 2002 Apr;11 Suppl A:303-5.
Rondeau V. A review of epidemiologic studies on aluminum and silica in relation to Alzheimer's disease and associated disorders. Rev Environ Health. 2002 Apr-Jun;17(2):107-21.
Demattos RB, Bales KR, Parsadanian M, O'Dell MA, Foss EM, Paul SM, Holtzman DM. Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease. J Neurochem. 2002 Apr;81(2):229-36.
Heun R, Kockler M, Ptok U. Psychiatric disorders in relatives of subjects with Alzheimer's disease No evidence for common genetic risk factors. Eur Arch Psychiatry Clin Neurosci. 2002 Apr;252(2):93-7.
Bao XM, Shu SY. Research progress in the structure and functions of the marginal division in the striatum. Di Yi Jun Yi Da Xue Xue Bao. 2002 Apr;22(4):289-95.
Christensen DD. Practical Principles for the Management of Alzheimer's Disease. Prim Care Companion J Clin Psychiatry. 2002 Apr;4(2):63-69.
Johnstone B, Hogg JR, Schopp LH, Kapila C, Edwards S. Neuropsychological deficit profiles in senile dementia of the Alzheimer's type. Arch Clin Neuropsychol. 2002 Apr;17(3):273-81.
Russo C, Venezia V, Salis S, Dolcini V, Schettini G. Molecular aspects of neurodegeneration in Alzheimer's disease. Funct Neurol. 2002 Apr-Jun;17(2):65-70.
Conti P, De Amici M, De Micheli C. Selective agonists and antagonists for kainate receptors. Mini Rev Med Chem. 2002 Apr;2(2):177-84.
Paris D, Townsend KP, Humphrey J, Obregon DF, Yokota K, Mullan M. Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae. Atherosclerosis. 2002 Apr;161(2):293-9.
Zambrano N, Bimonte M, Arbucci S, Gianni D, Russo T, Bazzicalupo P. feh-1 and apl-1, the Caenorhabditis elegans orthologues of mammalian Fe65 and beta-amyloid precursor protein genes, are involved in the same pathway that controls nematode pharyngeal pumping. J Cell Sci. 2002 Apr 1;115(Pt 7):1411-22.
Zingmark K, Sandman PO, Norberg A. Promoting a good life among people with Alzheimer's disease. J Adv Nurs. 2002 Apr;38(1):50-8.
Savaskan E, Wirz-Justice A, Olivieri G, Pache M, Kräuchi K, Brydon L, Jockers R, Müller-Spahn F, Meyer P. Distribution of melatonin MT1 receptor immunoreactivity in human retina. J Histochem Cytochem. 2002 Apr;50(4):519-26.
Sun A, Nguyen XV, Bing G. Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J Histochem Cytochem. 2002 Apr;50(4):463-72.
Small DH. Alzheimer's disease biomarkers: their value in diagnosis and clinical trials. Front Biosci. 2002 Apr 1;7:d986-8.
Shoji M. Cerebrospinal fluid Abeta40 and Abeta42: natural course and clinical usefulness. Front Biosci. 2002 Apr 1;7:d997-1006.
de la Monte SM, Wands JR. The AD7c-ntp neuronal thread protein biomarker for detecting Alzheimer's disease. Front Biosci. 2002 Apr 1;7:d989-96.
Gibson GE, Huang HM. Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease. Front Biosci. 2002 Apr 1;7:d1007-15.
Scacchi R, Ruggeri M, Gambina G, Martini MC, Corbo RM. Alpha2-macroglobulin deletion polymorphism and plasma levels in late onset Alzheimer's disease. Clin Chem Lab Med. 2002 Apr;40(4):333-6. ,
Llanos RM, Mercer JF. The molecular basis of copper homeostasis copper-related disorders. DNA Cell Biol. 2002 Apr;21(4):259-70.
Herrera Jr E, Caramelli P, Silveira AS, Nitrini R. Epidemiologic survey of dementia in a community-dwelling brazilian population. Alzheimer Dis Assoc Disord. 2002 Apr-Jun;16(2):103-8.
Sahadevan S, Lim JP, Tan NJ, Chan SP. Psychometric identification of early Alzheimer disease in an elderly chinese population with differing educational levels. Alzheimer Dis Assoc Disord. 2002 Apr-Jun;16(2):65-72.
Hsu YY, Schuff N, Amend DL, Du AT, Norman D, Chui HC, Jagust WJ, Weiner MW. Quantitative magnetic resonance imaging differences between Alzheimer disease with and without subcortical lacunes. Alzheimer Dis Assoc Disord. 2002 Apr-Jun;16(2):58-64.
Hook VY, Toneff T, Aaron W, Yasothornsrikul S, Bundey R, Reisine T. Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles. J Neurochem. 2002 Apr 1;81(2):237-56.
Carson JA, Turner AJ. Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J Neurochem. 2002 Apr;81(1):1-8.
Zhang S, Janciauskiene . Multifunctional capability of proteins: a1-antichymotrypsin and the correlation with Alzheimer’s disease. J Alzheimer’s Disease. 2002 Apr;4(2):115-122. Abstract
Davies RR, Xuereb JH, Hodges JR. The human perirhinal cortex in semantic memory: an in vivo and postmortem volumetric magnetic resonance imaging study in semantic dementia, Alzheimer's disease and matched controls. Neuropathol Appl Neurobiol. 2002 Apr;28(2):167-8.
Leclercq PD, Graham DI, Nicoll JA, Gentleman SM. Influence of ApoE genotype on cerebral amyloid angiopathy after closed head-injury. Neuropathol Appl Neurobiol. 2002 Apr;28(2):161-2.
Yow HY, Weller RO. A role for cerebrovascular disease in determining the pattern of beta-amyloid deposition in Alzheimer's disease. Neuropathol Appl Neurobiol. 2002 Apr;28(2):149.
Grön G, Bittner D, Schmitz B, Wunderlich AP, Riepe MW. Subjective memory complaints: Objective neural markers in patients with Alzheimer's disease and major depressive disorder. Ann Neurol. 2002 Apr;51(4):491-498.
Harman D. Alzheimer's disease: role of aging in pathogenesis. Ann N Y Acad Sci. 2002 Apr;959:384-95; discussion 463-5.
Mungarro-Menchaca X, Ferrera P, Morán J, Arias C. beta-Amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine. J Neurosci Res. 2002 Apr 1;68(1):89-96.
Chan A, Tam J, Murphy C, Chiu H, Lam L. Utility of olfactory identification test for diagnosing chinese patients with Alzheimer's disease. J Clin Exp Neuropsychol. 2002 Apr;24(2):251-9.
Rouleau I, Salmon DP, Vrbancic M. Learning, retention and generalization of a mirror tracing skill in Alzheimer's disease. J Clin Exp Neuropsychol. 2002 Apr;24(2):239-50.
Masterman T, Zhang Z, Hellgren D, Salter H, Anvret M, Lilius L, Lannfelt L, Hillert J. APOE genotypes and disease severity in multiple sclerosis. Mult Scler. 2002 Apr;8(2):98-103.
Bresciani LG, Walsh DT, Jen LS, Gentleman SM. In vivo investigations of presenilin 1: from development to pathology. Neuropathol Appl Neurobiol. 2002 Apr;28(2):162-3.
Holton JL, Ghiso J, Lashley T, Ganguly M, Strand K, Rostagno A, Plant G, Frangione B, Revesz T. Familial British dementia (FBD): a cerebral amyloidosis with systemic amyloid deposition. Neuropathol Appl Neurobiol. 2002 Apr;28(2):148.
Aisen PS. Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease. J Pain Symptom Manage. 2002 Apr;23(4 Suppl):S35-40.
Pappolla MA, Simovich MJ, Bryant-Thomas T, Chyan YJ, Poeggeler B, Dubocovich M, Bick R, Perry G, Cruz-Sanchez F, Smith MA. The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors. J Pineal Res. 2002 Apr;32(3):135-42.
Tabira T, Chui DH, Kuroda S. Significance of intracellular Abeta42 accumulation in Alzheimer's disease. Front Biosci. 2002 Apr 1;7:a44-9.
Adlard PA, Vickers JC. Morphologically distinct plaque types differentially affect dendritic structure and organisation in the early and late stages of Alzheimer's disease. Acta Neuropathol (Berl). 2002 Apr;103(4):377-83.
Rössler M, Zarski R, Bohl J, Ohm TG. Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathol (Berl). 2002 Apr;103(4):363-9.
Wegiel J, Kuchna I, Wisniewski T, de Leon MJ, Reisberg B, Pirttila T, Kivimaki T, Lehtimaki T. Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndrome. Acta Neuropathol (Berl). 2002 Apr;103(4):333-43.
No comments:
Post a Comment